{"id":"https://genegraph.clinicalgenome.org/r/900729ca-3226-4e15-9f37-1bd262c3d8f8v1.0","type":"EvidenceStrengthAssertion","dc:description":"*MYBPC3* was first reported in relation to autosomal dominant congenital heart disease in 2011 (Posch et al., PMID: 22194935). Nine variants (missense, nonsense, splice acceptor) that have been reported in 10 probands with CHD in eight publications (PMIDs: 22194935, 27418595, 28991257, 31440271, 33209723, 35146008, 34670123, 35885957) are included in this curation, but only three variants were scored, as the other variants were present in unaffected family members and/or too frequent in population databases. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (expression data; PMID: 28315668). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the Congenital Heart Disease GCEP on July 8th, 2024 (SOP Version 10)","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/900729ca-3226-4e15-9f37-1bd262c3d8f8","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-10-07T20:11:41.402Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-07-08T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08dc425e-cd38-4e71-b377-a34387ab6a20","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.002209 (2606/1179908) in non-Finnish Europeans, which is too frequent to be pathogenic.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08dc425e-cd38-4e71-b377-a34387ab6a20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22194935","allele":{"id":"https://genegraph.clinicalgenome.org/r/c30657a8-4a43-490e-a36b-f8d1455e3416","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.2497G>A (p.Ala833Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA012381"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ac15f04b-4f8d-4720-b5bb-69f9c22ff4db","type":"EvidenceLine","dc:description":"The proband is reported to have inherited the variant from an unaffected parent. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac15f04b-4f8d-4720-b5bb-69f9c22ff4db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28991257","allele":{"id":"https://genegraph.clinicalgenome.org/r/527ef97d-c1a6-4cb7-bf77-2c047d628392","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.3208C>T (p.Gln1070Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380314493"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/043bc83c-a0b7-442a-802a-7c91917a3aa2","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/043bc83c-a0b7-442a-802a-7c91917a3aa2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34670123","allele":{"id":"https://genegraph.clinicalgenome.org/r/78978673-6152-4448-9e61-50e3b9946dae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.2526C>G (p.Tyr842Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380318188"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/51c55989-6706-4390-885d-ee0d0aa085ac","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.00002 (219/1179190) in non-Finnish Europeans, which is too frequent to be pathogenic. Additionally, the proband is reported to have inherited the variant from an unaffected parent. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51c55989-6706-4390-885d-ee0d0aa085ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28991257","allele":{"id":"https://genegraph.clinicalgenome.org/r/1624bd6f-7ebf-4235-aba5-4158c4241609","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.1928-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA011513"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/65cef575-0c9d-408a-adc1-9131d1313fdf","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65cef575-0c9d-408a-adc1-9131d1313fdf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35146008","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c00d0ce-2b12-4be6-876c-a4c19990815c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.1574A>C (p.Tyr525Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380325074"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1bb54682-985a-4d98-974f-d59e7cdd65ab","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bb54682-985a-4d98-974f-d59e7cdd65ab_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR and Western blot results showed that both Mybpc3 mRNA levels and protein levels in the proband and her affected father who carried the same variant were almost half of the probandâ€™s unaffected mother.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1bb54682-985a-4d98-974f-d59e7cdd65ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33209723","allele":{"id":"https://genegraph.clinicalgenome.org/r/98cd76e6-73aa-40e2-ac67-1b4215be80d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.173C>T (p.Ala58Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380341777"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f01014b5-a787-4f87-9a5e-a50b8212cb03","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.002209 (2606/1179908) in non-Finnish Europeans, which is too frequent to be pathogenic.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f01014b5-a787-4f87-9a5e-a50b8212cb03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22194935","allele":{"id":"https://genegraph.clinicalgenome.org/r/c30657a8-4a43-490e-a36b-f8d1455e3416"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9e011c11-4766-4197-a1ea-b3680d001572","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.0008860 (26/29344) in Ashkenazi Jewish, which is too frequent to be pathogenic. The proband was also found to have an additional variant in a gene that is known to be associated with congenital heart disease (SOS1). ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e011c11-4766-4197-a1ea-b3680d001572_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27418595","allele":{"id":"https://genegraph.clinicalgenome.org/r/2dea6d7d-3a73-4f66-aa81-14427c5a6256","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.961G>A (p.Val321Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA016189"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bd07937a-d53f-484c-94b6-a5bb665ab9fa","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.0003169 (19/59948) in Admixed Americans, which is too frequent to be pathogenic.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd07937a-d53f-484c-94b6-a5bb665ab9fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35885957","allele":{"id":"https://genegraph.clinicalgenome.org/r/6cf63b73-e682-479f-a4a7-619e2061d54b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.2176C>T (p.Arg726Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA078569"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3697e01b-b264-4578-a208-37d3acbb2fb1","type":"EvidenceLine","dc:description":"The gnomAD v4.1.0 MAF is 0.005370 (403/75046) in African/African Americans, which is too frequent to be pathogenic. Additionally, the proband was reported to have inherited the variant from an unaffected parent. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3697e01b-b264-4578-a208-37d3acbb2fb1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31440271","allele":{"id":"https://genegraph.clinicalgenome.org/r/d00f83e8-708b-4bab-b792-2593492b9cc8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000256.3(MYBPC3):c.1519G>A (p.Gly507Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA010550"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.1},{"id":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cbe41f1-7421-4efe-ac33-6ff3fa530b43_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a5aace5-0599-4575-8396-7153a587f051","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bba057dc-f33f-4105-aa65-ba1887003e8b","type":"Finding","dc:description":"Western blot was performed to compare the expression of cMyBP-C (MYBPC3) in 18 normal controls and 16 fetuses with CHD. Western blotting confirmed cMyBP-C expression in amniotic fluid and fetal heart tissues, demonstrating significantly reduced cMyBP-C in fetuses with CHD compared with normal controls. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28315668","rdfs:label":"Expression in human fetuses with CHD","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":9139,"specifiedBy":"GeneValidityCriteria10","strengthScore":2.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/a_mKN35K9Fc","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:7551","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2cbe41f1-7421-4efe-ac33-6ff3fa530b43-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}